Clinical Trials Directory

Trials / Completed

CompletedNCT01695018

Early Diagnosis of Oral Cancer by Detecting p16 Methylation

A Multicentral Prospective Study on Prediction of Malignant Progression of Oral Epithelial Dysplasia With p16 Methylation

Status
Completed
Phase
Study type
Observational
Enrollment
180 (actual)
Sponsor
Peking University · Academic / Other
Sex
All
Age
25 Years – 78 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to verify the function of p16 methylation diagnostic reagents in early diagnosis of oral cancer.

Detailed description

Background:Oral epithelial dysplasia (OED) is one of the common precancerous lesions among Chinese adults. To investigate the clinical predictive value of p16 methylation diagnostic reagents in the early diagnosis of oral cancer, the investigators carried out the prospective multi-center double-blind cohort study. Methods:180 patients with histologically confirmed mild or moderate OED were included in the present study. The investigators using p16 methylation diagnostic reagents to analysis of the p16 methylation status in these patients. Building two follow-up queue by p16-methylated and p16-unmethylated. The Statistical analysis used SAS6.12 software. All P-values were two-sided. P\<0.05 was considered to test for statistical significance difference.

Conditions

Timeline

Start date
2009-02-01
Primary completion
2014-03-01
First posted
2012-09-27
Last updated
2014-09-25

Source: ClinicalTrials.gov record NCT01695018. Inclusion in this directory is not an endorsement.